← Leaderboards
Yutaka Yasui
St. Jude Children'S Research Hospital
$5,067,179
Attributed
$11,112,175
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,112,175 · 4
By mechanism
R01$11,112,175 · 4
Top collaborators
- Rebecca Maureen Howell6 shared
- Daniel A. Mulrooney6 shared
- Jinghui Zhang5 shared
- Nickhill Hitesh Bhakta4 shared
- I-Chan Huang4 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Kevin R Krull$10,966,065
- Melissa M Hudson$11,170,550
- Kirsten Kimberlie Ness$15,600,609
- I-Chan Huang$3,780,444
- Nickhill Hitesh Bhakta$921,678
Others in their field
Other Emerging Leaders on “Childhood Cancer Survivor”
- Crystal Mackall · Children'S Hosp Of Philadelphia$9,227,921
- Tara M Brinkman · St. Jude Children'S Research Hospital$7,429,723
- Kimberly Ann Miller · University Of Southern California$6,999,969
- Adam De Smith · University Of Southern California$5,030,079
- Leonard Freedman · Leidos Biomedical Research, Inc.$4,746,240
- Paul Northcott · St. Jude Children'S Research Hospital$4,059,302
Research focus
Childhood Cancer SurvivorFutureSaint Jude Children&AposS Research HospitalCaringCohortCohort StudiesSurvivorsChronicMalignant NeoplasmsChildPersonalized Risk PredictionAdultMorbidity - Disease RateRisk Prediction ModelRisk PredictionRisk FactorsSurvivorshipDoseProspectiveCessation Of LifePrematureReportingClinical Practice
Grant awards (19)
Patient-Generated Health Data to Predict Childhood Cancer Survivorship Outcomes$1,131,433
R01 · FY2025 · CA
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors$780,452
R01 · FY2025 · CA
Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts$502,584
R01 · FY2025 · CA
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors$86,073
R01 · FY2025 · CA
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors$769,340
R01 · FY2024 · CA
Patient-Generated Health Data to Predict Childhood Cancer Survivorship Outcomes$298,816
R01 · FY2024 · CA
Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts$98,612
R01 · FY2024 · CA
Research Supplements to Promote Diversity in Health-Related Research: Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors$86,073
R01 · FY2024 · CA
Patient-Generated Health Data to Predict Childhood Cancer Survivorship Outcomes$727,399
R01 · FY2023 · CA
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors$701,204
R01 · FY2023 · CA
Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts$664,318
R01 · FY2023 · CA
Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts$577,841
R01 · FY2022 · CA
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors$510,311
R01 · FY2022 · CA
Patient-Generated Health Data to Predict Childhood Cancer Survivorship Outcomes$742,807
R01 · FY2021 · CA
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing$628,281
R01 · FY2021 · CA · contact PI
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing$628,281
R01 · FY2020 · CA · contact PI
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing$728,864
R01 · FY2019 · CA · contact PI
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing$716,706
R01 · FY2018 · CA · contact PI
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing$732,780
R01 · FY2017 · CA · contact PI